Suchergebnisse - "Fehn, Karen"

PubPharm (28)

11

Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC

enthalten in: medRxiv : the preprint server for health sciences | 2020

von Yoon, H. | Bartash, R. | Gendlina, I. | +52

UpdateIn: JCI Insight. 2021 Feb 22;6(4):. - PMID 33476300

12

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

enthalten in: Journal of hematology & oncology | 2020

von Abbasi, A. | Peeke, S. | Shah, N. | +21

13

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

enthalten in: Journal of hematology & oncology | 2020

von Abbasi, A. | Peeke, S. | Shah, N. | +21

14

Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer

enthalten in: Clinical breast cancer | 2018

von Anampa, J. | Chen, A. | Wright, J. | +5

15

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

16

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

17

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

18

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

19

Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

enthalten in: Breast cancer research and treatment | 2013

von Andreopoulou, E. | Vigoda, I. | Valero, V. | +11

20

Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

enthalten in: Breast cancer research and treatment | 2013

von Andreopoulou, E. | Vigoda, I. | Valero, V. | +11